GenScript
Piscataway, NJ / Nanjing, China
Compare CAR-T CDMOs in Asia
Compare CAR-T CDMOs in China
Compare Cell Therapy CDMOs in Asia
Compare Cell Therapy CDMOs in China
Compare Gene Editing CDMOs in Asia
Compare Gene Editing CDMOs in China
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
64.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (19)
○ EMA GMP
○ MHRA GMP
Quick Facts: GenScript
- Signal Score
- 64.0/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Piscataway, NJ / Nanjing, China
- Modalities
- CAR-T, Cell Therapy, Gene Editing
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About GenScript
BIOSECURE Act exposure via China operations.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, Gene Editing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
65.0
Publicly traded — financial transparency
BIOSECURE Act exposure risk
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Publicly traded — financial transparency
BIOSECURE Act exposure risk
Capacity
63.0
2 manufacturing sites
Sites: Piscataway, NJ, Nanjing, China
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
Press Signals19 articles (not scored)
2 manufacturing sites
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No count for this company yet. The careers board we can read covers more than this business (85 postings on Nov 21, 2026), and we can't yet tell which of those roles belong to it. Why: the board covers the whole group and doesn't say which business unit a role belongs to. We'd rather show no number than one that isn't really this company's.
Source:
greenhouse
· Checked Nov 21, 2026
Company Signals 19 articles
Company announcements, not verified evidence. They do not change any score.
GenScript Biotech rose more than 5% in early trading as Eli Lilly and Co announced a $7 billion acquisition of an in vivo CAR-T company. - 富途牛牛
GenScript Biotech rose more than 5% in early trading as Eli Lilly and Co announced a $7 billion acquisition of an in vivo CAR-T company. 富途牛牛
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - BioSpace
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era BioSpace
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Dailyhunt
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era Dailyhunt
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - The Manila Times
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era The Manila Times
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Thailand Business News
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era Thailand Business News
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - Bolsamania
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era Bolsamania
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era - TNGlobal
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era TNGlobal
GenScript reports strong fiscal 2025 results from platform strategy - Vietnam Investment Review - VIR
GenScript reports strong fiscal 2025 results from platform strategy Vietnam Investment Review - VIR
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership Indian Pharma Post
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth - Bolsamania
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth Bolsamania
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership - Indian Pharma Post
GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership Indian Pharma Post
GenScript opens its first European mRNA production site - Scientist Live
GenScript opens its first European mRNA production site Scientist Live
GenScript opens its first European mRNA production site - Scientist Live
GenScript opens its first European mRNA production site Scientist Live
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - BioSpace
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub BioSpace
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - The AI Journal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub The AI Journal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - BeBeez International
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub BeBeez International
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform - BioPharma APAC
GenScript Opens First European mRNA Production Facility In Delft Strengthening Global Biotechnology Platform BioPharma APAC
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub - TNGlobal
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub TNGlobal
Frequently Asked Questions About GenScript
What is GenScript's CDMO Signal Score?
GenScript has a Signal Score of 64/100, based on quality, operations, financial stability, and capacity data.
Evaluating GenScript for a manufacturing program?
Use the free AI matchmaker to compare GenScript against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 79.3
CAR-T, Cell Therapy, iPSC, Gene Editing
CTMC
Houston, TX
Signal Score: 63.0
CAR-T, Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 87.0
CAR-T, Cell Therapy
Compare GenScript with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.